Low concentrations of 17β-estradiol protect single cardiac cells against metabolic stress-induced CA2+ loading

Sofija Jovanovǐ, Aleksandar Jovanovǐ, Win K. Shen, Andre Terzic

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

OBJECTIVES: The main objective of the present study was to determine whether low physiological levels of estrogen directly protect cardiac cells against metabolic stress. BACKGROUND: The beneficial effect of estrogens on the cardiovascular system has been traditionally ascribed to decrease in peripheral vascular resistance and to an antiatherogenic action. Whether physiological concentrations of 17β-estradiol (E2) are also able to protect cardiomyocytes against metabolic insult directly is unknown. METHODS: Isolated ventricular cardiomyocytes were loaded with the Ca2+-sensitive fluorescent dye Fluo-3 and imaged by a digital epifluorescence imaging system. In cardiac cells preincubated with hormones and/or drugs for 8 h, metabolic stress was induced by addition and removal of 2,4-dinitrophenol (DNP). RESULTS: In cardiomyocytes, a 3-min-long exposure to chemical hypoxia, followed by reoxygenation, produced intracellular Ca2+ loading independently of gender (female: 729 ± 88 nmol/liter; male: 778 ± 97 nmol/liter). Pretreatment with E2 (10 nmol/liter) significantly reduced the magnitude of hypoxia/reoxygenation-induced Ca2+ loading in female (E2-treated: 298 ± 39 nmol/liter; untreated: 729 ± 88 nmol/liter), but not in male (E2-treated: 1029 ± 177 nmol/liter; untreated: 778 ± 97 nmol/liter) cardiac cells. The protective action of E2 was not mimicked by the inactive estrogen stereoisomer, 10 nmol/liter 17α estradiol (17α estradiol-treated: 886 ± 122 nmol/liter; untreated: 729 ± 88 nmol/liter), and was abolished by tamoxifen (1 μmol/liter), which acts as an antagonist of E2 on estrogen receptors (E2 plus tamoxifen-treated: 702 ± 98 nmol/liter; untreated: 729 ± 88 nmol/liter). CONCLUSIONS: In a gender-dependent manner, E2 directly protects cardiac cells against hypoxia-reoxygenation injury through an estrogen receptor-mediated mechanism. Such property of E2 may contribute to cardioprotection in the female gender. (C) 2000 by the American College of Cardiology.

Original languageEnglish (US)
Pages (from-to)948-952
Number of pages5
JournalJournal of the American College of Cardiology
Volume36
Issue number3
DOIs
StatePublished - 2000

Fingerprint

Physiological Stress
Cardiac Myocytes
Estradiol
Estrogens
Tamoxifen
Estrogen Receptors
Vascular Resistance
2,4-Dinitrophenol
Cell Hypoxia
Stereoisomerism
Cardiovascular System
Fluorescent Dyes
Hormones
Wounds and Injuries
Pharmaceutical Preparations
Hypoxia

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Low concentrations of 17β-estradiol protect single cardiac cells against metabolic stress-induced CA2+ loading. / Jovanovǐ, Sofija; Jovanovǐ, Aleksandar; Shen, Win K.; Terzic, Andre.

In: Journal of the American College of Cardiology, Vol. 36, No. 3, 2000, p. 948-952.

Research output: Contribution to journalArticle

@article{c247332677f143c1b601e58a3026a841,
title = "Low concentrations of 17β-estradiol protect single cardiac cells against metabolic stress-induced CA2+ loading",
abstract = "OBJECTIVES: The main objective of the present study was to determine whether low physiological levels of estrogen directly protect cardiac cells against metabolic stress. BACKGROUND: The beneficial effect of estrogens on the cardiovascular system has been traditionally ascribed to decrease in peripheral vascular resistance and to an antiatherogenic action. Whether physiological concentrations of 17β-estradiol (E2) are also able to protect cardiomyocytes against metabolic insult directly is unknown. METHODS: Isolated ventricular cardiomyocytes were loaded with the Ca2+-sensitive fluorescent dye Fluo-3 and imaged by a digital epifluorescence imaging system. In cardiac cells preincubated with hormones and/or drugs for 8 h, metabolic stress was induced by addition and removal of 2,4-dinitrophenol (DNP). RESULTS: In cardiomyocytes, a 3-min-long exposure to chemical hypoxia, followed by reoxygenation, produced intracellular Ca2+ loading independently of gender (female: 729 ± 88 nmol/liter; male: 778 ± 97 nmol/liter). Pretreatment with E2 (10 nmol/liter) significantly reduced the magnitude of hypoxia/reoxygenation-induced Ca2+ loading in female (E2-treated: 298 ± 39 nmol/liter; untreated: 729 ± 88 nmol/liter), but not in male (E2-treated: 1029 ± 177 nmol/liter; untreated: 778 ± 97 nmol/liter) cardiac cells. The protective action of E2 was not mimicked by the inactive estrogen stereoisomer, 10 nmol/liter 17α estradiol (17α estradiol-treated: 886 ± 122 nmol/liter; untreated: 729 ± 88 nmol/liter), and was abolished by tamoxifen (1 μmol/liter), which acts as an antagonist of E2 on estrogen receptors (E2 plus tamoxifen-treated: 702 ± 98 nmol/liter; untreated: 729 ± 88 nmol/liter). CONCLUSIONS: In a gender-dependent manner, E2 directly protects cardiac cells against hypoxia-reoxygenation injury through an estrogen receptor-mediated mechanism. Such property of E2 may contribute to cardioprotection in the female gender. (C) 2000 by the American College of Cardiology.",
author = "Sofija Jovanovǐ and Aleksandar Jovanovǐ and Shen, {Win K.} and Andre Terzic",
year = "2000",
doi = "10.1016/S0735-1097(00)00798-1",
language = "English (US)",
volume = "36",
pages = "948--952",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Low concentrations of 17β-estradiol protect single cardiac cells against metabolic stress-induced CA2+ loading

AU - Jovanovǐ, Sofija

AU - Jovanovǐ, Aleksandar

AU - Shen, Win K.

AU - Terzic, Andre

PY - 2000

Y1 - 2000

N2 - OBJECTIVES: The main objective of the present study was to determine whether low physiological levels of estrogen directly protect cardiac cells against metabolic stress. BACKGROUND: The beneficial effect of estrogens on the cardiovascular system has been traditionally ascribed to decrease in peripheral vascular resistance and to an antiatherogenic action. Whether physiological concentrations of 17β-estradiol (E2) are also able to protect cardiomyocytes against metabolic insult directly is unknown. METHODS: Isolated ventricular cardiomyocytes were loaded with the Ca2+-sensitive fluorescent dye Fluo-3 and imaged by a digital epifluorescence imaging system. In cardiac cells preincubated with hormones and/or drugs for 8 h, metabolic stress was induced by addition and removal of 2,4-dinitrophenol (DNP). RESULTS: In cardiomyocytes, a 3-min-long exposure to chemical hypoxia, followed by reoxygenation, produced intracellular Ca2+ loading independently of gender (female: 729 ± 88 nmol/liter; male: 778 ± 97 nmol/liter). Pretreatment with E2 (10 nmol/liter) significantly reduced the magnitude of hypoxia/reoxygenation-induced Ca2+ loading in female (E2-treated: 298 ± 39 nmol/liter; untreated: 729 ± 88 nmol/liter), but not in male (E2-treated: 1029 ± 177 nmol/liter; untreated: 778 ± 97 nmol/liter) cardiac cells. The protective action of E2 was not mimicked by the inactive estrogen stereoisomer, 10 nmol/liter 17α estradiol (17α estradiol-treated: 886 ± 122 nmol/liter; untreated: 729 ± 88 nmol/liter), and was abolished by tamoxifen (1 μmol/liter), which acts as an antagonist of E2 on estrogen receptors (E2 plus tamoxifen-treated: 702 ± 98 nmol/liter; untreated: 729 ± 88 nmol/liter). CONCLUSIONS: In a gender-dependent manner, E2 directly protects cardiac cells against hypoxia-reoxygenation injury through an estrogen receptor-mediated mechanism. Such property of E2 may contribute to cardioprotection in the female gender. (C) 2000 by the American College of Cardiology.

AB - OBJECTIVES: The main objective of the present study was to determine whether low physiological levels of estrogen directly protect cardiac cells against metabolic stress. BACKGROUND: The beneficial effect of estrogens on the cardiovascular system has been traditionally ascribed to decrease in peripheral vascular resistance and to an antiatherogenic action. Whether physiological concentrations of 17β-estradiol (E2) are also able to protect cardiomyocytes against metabolic insult directly is unknown. METHODS: Isolated ventricular cardiomyocytes were loaded with the Ca2+-sensitive fluorescent dye Fluo-3 and imaged by a digital epifluorescence imaging system. In cardiac cells preincubated with hormones and/or drugs for 8 h, metabolic stress was induced by addition and removal of 2,4-dinitrophenol (DNP). RESULTS: In cardiomyocytes, a 3-min-long exposure to chemical hypoxia, followed by reoxygenation, produced intracellular Ca2+ loading independently of gender (female: 729 ± 88 nmol/liter; male: 778 ± 97 nmol/liter). Pretreatment with E2 (10 nmol/liter) significantly reduced the magnitude of hypoxia/reoxygenation-induced Ca2+ loading in female (E2-treated: 298 ± 39 nmol/liter; untreated: 729 ± 88 nmol/liter), but not in male (E2-treated: 1029 ± 177 nmol/liter; untreated: 778 ± 97 nmol/liter) cardiac cells. The protective action of E2 was not mimicked by the inactive estrogen stereoisomer, 10 nmol/liter 17α estradiol (17α estradiol-treated: 886 ± 122 nmol/liter; untreated: 729 ± 88 nmol/liter), and was abolished by tamoxifen (1 μmol/liter), which acts as an antagonist of E2 on estrogen receptors (E2 plus tamoxifen-treated: 702 ± 98 nmol/liter; untreated: 729 ± 88 nmol/liter). CONCLUSIONS: In a gender-dependent manner, E2 directly protects cardiac cells against hypoxia-reoxygenation injury through an estrogen receptor-mediated mechanism. Such property of E2 may contribute to cardioprotection in the female gender. (C) 2000 by the American College of Cardiology.

UR - http://www.scopus.com/inward/record.url?scp=0033624571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033624571&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(00)00798-1

DO - 10.1016/S0735-1097(00)00798-1

M3 - Article

C2 - 10987624

AN - SCOPUS:0033624571

VL - 36

SP - 948

EP - 952

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 3

ER -